Therapeutic Remodeling of the Gut Microbiome as a Strategy to Restore Immune Tolerance in Autoimmunity
Open Access
- 19 April 2026
- journal article
- review article
- Published by Wiley in Microbiologyopen
- Vol. 15 (2) , e70294
Abstract
Autoimmune diseases happen when the immune system, which is supposed to defend the body from infections and other harmful things, starts to attack the body's own cells by mistake. In the last few years, they seem to be getting more public, and the reasons are quite complicated. It is usually not just one factor, but a mix of genes and environmental influences, such as diet, infections, or even stress. The gut microbiome, the vast community of bacteria and other tiny organisms living in our intestines, plays an important role in shaping how the immune system behaves. When this gut microbiota becomes unstable (a state called dysbiosis), it can be associated with the onset or worsening of various autoimmune diseases. In this review, we discuss the close relationship between the gut microbiome and autoimmune disorders and focus on how the microbiome can affect immune activation, immune tolerance, and inflammation at the molecular level. The general idea is that, if we understand these interactions better, we might be able in the future to design new ways to manage autoimmune diseases earlier and maybe in a more personalized way. In the end, the review suggests that if we understand better how the microbiome is involved in autoimmune diseases, it might be possible in the future to design more personalized therapies that change gut bacteria in a smart way and hopefully improve patient outcomes.Keywords
This publication has 116 references indexed in Scilit:
- Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severityScientific Reports, 2017
- Selfie: Autoimmunity, boon or baneJournal of Immunoassay and Immunochemistry, 2016
- Protein kinase CK2 governs the molecular decision between encephalitogenic T H 17 cell and T reg cell developmentProceedings of the National Academy of Sciences, 2016
- Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trialInternational Journal of Rheumatic Diseases, 2016
- The Gut-Brain Axis: The Missing Link in DepressionClinical Psychopharmacology and Neuroscience, 2015
- The administration of probiotics and synbiotics in immune compromised adults: is it safe?Beneficial Microbes, 2015
- Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trialInternational Journal of Rheumatic Diseases, 2014
- A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitisNutrition, 2009
- The Safety of ProbioticsClinical Infectious Diseases, 2008
- Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot studyScandinavian Journal of Rheumatology, 2003